DQE-28203-64303 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-10
Dose 1 — Pfizer-BioNTech
2021-03-24
Dose 2 — Pfizer-BioNTech
2021-12-07
Dose 3 — Pfizer-BioNTech
2022-11-30
Dose 4 — Pfizer-BioNTech
2022-12-02
Registered in v-safe
2022-12-02
Survey response — days 1–6 daily, dose 4
MedDRA: Cough, Hypogeusia, Hyposmia, Respiratory tract congestion — Feeling: Poor · Be unable to do your normal daily activities

Free text: Congestion, cough, reduced taste and smell

MedDRA releases: 2024-11 · check-in free text available
2022-12-03
Survey response — days 1–6 daily, dose 4
MedDRA: Cough, Nasal congestion — Feeling: Poor · Be unable to do your normal daily activities

Free text: Nasal congestion, cough

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-10	Pfizer-BioNTech	No
2	2021-03-24	Pfizer-BioNTech	No
3	2021-12-07	Pfizer-BioNTech	No
4	2022-11-30	Pfizer-BioNTech	No

Free text

Release 12 — days 1–6 daily, dose 4

2022-12-02

Systemic reaction (other): Congestion, cough, reduced taste and smell

2022-12-03

Systemic reaction (other): Nasal congestion, cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Cough	·	·	✓
SRO	Hypogeusia	·	·	✓
SRO	Hyposmia	·	·	✓
SRO	Nasal congestion	·	·	✓
SRO	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release